INTENDED USE The Finecare™ β2-MG Rapid Quantitative Test is a fluorescence immunoassay used along with Finecare™ FIA System for quantitative determination of β2-MG (Beta-2-Microglobulin) concentration in human plasma, serum or whole blood. The test is used as an aid for the diagnosis of renal disease. STORAGE AND STABILITY 1. Store the test kit at 4℃~30℃ up to the expiration date printed on package. 2. If removed from refrigerator, allow the test kit for 30 minutes to return to room temperature before testing. 3. Do not remove the Test Cartridge from the pouch until use. The Test Cartridge should be used within 1 hour once opened.

The FineCare FIA Meter II plus SE is a top-class fluorescence immunoassay analyzer with a built-in thermal printer, Wifi, internet connectivity, large LCD display for testing common clinical diseases. Description The FineCare FIA Meter II plus is a top-class fluorescence immunoassay analyzer with a built-in thermal printer, Wifi, and internet connectivity, large LCD display for testing common clinical diseases. Technical Specifications Analyses common clinical diseases such as Diabetic & Renal injury Markers, Thyroid function, Fertility, Cardiac Markers, Inflammation Markers, Tumour Markers Built-in Thermal Printer Real-time auto printing Support for external printer Dimension :- 239mm x 278mm x 148mm Weight : 3.3kg Large Display 8” LCD Capacitive touch screen Intuitive user interface Specially designed sampler for a small volume of the specimen. Test Reagent Suitable for whole blood, serum, plasma, and urine Room temperature storage Get results in 3 -15 minutes Test Device Tray Multiple testing modes available Unique quick mode for a large number of samples Keywords large number fluorescence small volume Cardiac Markers Thyroid function large LCD display Inflammation Markers Renal injury Markers internet connectivity common clinical diseases LCD Capacitive touch screen Intuitive user Built-in Thermal Printer Immunoassay Analyzer, Finecare Analyzer, TSH, HbA1c, Point of care , immunoassay, Clia Analyses common clinical diseases such as Diabetic & Renal injury Markers, Thyroid function, Fertility, Cardiac Markers, Inflammation Markers, Tumour Markers

Getein 1180 Immunofluorescence Quantitative Analyzer is used to measure the concentration of biomarkers in human whole blood, serum, plasma, urine, nasal swab, or saliva samples. Getein 1180 Immunofluorescence Quantitative Analyzer (hereinafter called Getein 1180) is an analyzer for processing and analysis of Getein test kits including biomarkers for cardiovascular diseases, renal function, inflammation, fertility, diabetes mellitus, bone metabolism, tumor, and thyroid function, etc. Getein 1180 is used to measure the concentration of biomarkers in human whole blood, serum, plasma, urine, nasal swab, or saliva samples. The results can be used as an aid in clinical diagnosis of laboratory and point-of-care testing. It is applicable in Emergency, Clinical labs, Outpatient, ICU, CCU, Cardiology, Ambulance, Inpatient Wards, etc.

Palm-sized, fitting easily into a doctor's bag or uniform pocket. The printer can be separated from the "PocketChem" analyzer, leaving it with a weight of just 180g. Corrective features for obtaining accurate test results Accurate readings can be obtained by eliminating the effects of chromaturia using the color correction test pad, by compensating measurements for the temperature of the surrounding environment using a built-in temperature sensor and by correcting specific gravity based on pH readings. Palm-sized analyzer driven by two batteries The analyzer is detachable from the printer. The analyzer is really portable and mobile. Simple operation. Just press the start button Measurement is performed by simply pressing the start button and placing a test strip. Test results can be simultaneously viewed on the display and printed out from the printer. Reliable test results with Creatinine correction Even with the use of spot urine, test results are reliable and are not affected by urine dilutions or concentrations. The P/C ration or A/C ratio is effective for the screening of renal diseases. Sample Urine Test strips AUTION Sticks/ Uriflet S (9UB)* / AUTION SCREEN * Except devices with 10V specifications Measurement items GLU (glucose), PRO (protein), BIL (bilirubin), URO (urobilinogen), S.G. (specific gravity), BLD (blood), PH (pH), KET (ketones), NIT (nitrite), LEU (leukocytes), CRE (creatinine) and ALB (albumin). Measurement principle Test strip: Dual wavelength reflectance method. (one wavelength for BLD measurement) Measurement wavelengths 3 wavelengths LED (565, 635, 760 nm) Sample supply method Manual dipping Measurement capacity 50 tests per hour Test strip reaction time About 60 seconds per test Measurement types Normal measurement and check measurement Display Custom LCD that displays information including type of test strip, measurement number (up to 4 digits), patient ID (up to 13 digits) and test results. Operator panel Panel sheet that provides 14 buttons including numeric buttons and start button. Memory capacity Test results for 100 samples External output Compliant with RS-232 C Measurement environment Temperature: 10 to 30 °C; Humidity: 30 to 60 % R.H. (non-condensing) *Temperature correction function used Dimensions 124 (W) x 81 (D) x 36 (H) mm Weight 180 g (without batteries) Power supply Instrument only: Two AA alkaline batteries or AC adapter Instrument with printer: AC adapter 7.5 V 3 A Power consumption 3 W Printer specifications Printer Thermal recording printer Printer paper High color development thermal paper (W 58 mm x φ26 mm) Dimensions 125 (W) x 133 (D) x 36 (H) mm Weight 180 g (without printer paper) Power supply AC adapter 7.5 V 3 A Power consumption 20 W

Buy AccuTest COVID-19 IgG/IgM Rapid Test (Pack of 10 Tests) Online. COVID-19 IgG/IgM Rapid Test Kit is a qualitative immuno chromatographic assay for the detection of IgG & IgM antibodies produced against COVID-19 virus in human whole blood/Serum/ Plasma. COVID-19 IgG/IgM Rapid Test Kit is only intended for initial screening and reactive samples should be confirmed by a supplemental assay. Intended Use: COVID-19 IgG/IgM Rapid Test Kit is a qualitative immuno chromatographic assay for the detection of IgG & IgM antibodies produced against COVID-19 virus in human whole blood/Serum/ Plasma. COVID-19 IgG/IgM Rapid Test Kit is only intended for initial screening and reactive samples should be confirmed by a supplemental assay. SUMMARY & TEST DESCRIPTION: COVID-19 [Coronavirus Disease- 2019] is an infectious disease caused by SARS-CoV2 [Severe Acute Respiratory Syndrome coronavirus 2] virus, which is a contagious, novel strain of CoronaVirus that emerged from Wuhan, China in December 2019, which grew as a pandemic threatening human survival across the globe. The virus is thought to be of zoonotic origin and likely to have spread from large seafood and animal markets by human-animal contact in the city of Wuhan, where consumption of such products is in large. The virus causes respiratory infection with symptoms including fatigue, fever, shortness of breath, respiratory failure, renal failure and death. Patients can become infected with SARS-CoV-2 virus by person-person contact (through contact with a contaminated environment or person). The young and old (and other immune-compromised individuals) are most at risk of serious complications; however, approximately 20% of those infected can develop a critical condition. COVID-19 IgG/IgM Rapid Test device utilizes Anti-human IgG and Anti-human IgM antibodies as the capture molecules. COVID-19 Recombinant Antigens-colloidal gold conjugate are used as detection antigen. Intended Use: COVID-19 IgG/IgM Rapid Test Kit is a qualitative immuno chromatographic assay for the detection of IgG & IgM antibodies produced against COVID-19 virus in human whole blood/Serum/ Plasma. COVID-19 IgG/IgM Rapid Test Kit is only intended for initial screening and reactive samples should be confirmed by a supplemental assay. SUMMARY & TEST DESCRIPTION: COVID-19 [Coronavirus Disease- 2019] is an infectious disease caused by SARS-CoV2 [Severe Acute Respiratory Syndrome coronavirus 2] virus, which is a contagious, novel strain of CoronaVirus that emerged from Wuhan, China in December 2019, which grew as a pandemic threatening human survival across the globe. The virus is thought to be of zoonotic origin and likely to have spread from large seafood and animal markets by human-animal contact in the city of Wuhan, where consumption of such products is in large. The virus causes respiratory infection with symptoms including fatigue, fever, shortness of breath, respiratory failure, renal failure and death. Patients can become infected with SARS-CoV-2 virus by person-person contact (through contact with a contaminated environment or person). The young and old (and other immune-compromised individuals) are most at risk of serious complications; however, approximately 20% of those infected can develop a critical condition. COVID-19 IgG/IgM Rapid Test device utilizes Anti-human IgG and Anti-human IgM antibodies as the capture molecules. COVID-19 Recombinant Antigens-colloidal gold conjugate are used as detection antigen. PRECAUTIONS & WARNING 1. This package insert must be read completely before performing thetest. Failuretofollow directions in insert may yield inaccurate test results. 2. Test results should be read between 10 and 15 minutes after aspecimenisapplied to the sample well. Results read after 20 minutes may giveerroneousresults.3. Do not open the sealed pouch until you are ready to conduct theassay.Onceopened, the cassettes should be used immediately. 4. Do not use expired devices. 5. Bring all reagents to room temperature (15-30°C) prior to use. 6. Do not mix components from different kits. Use only the buffer suppliedalongwith the kit. 7. Wear protective clothing and disposable gloves while handling thekit reagentsand clinical specimens. Wash hands thoroughly after performing thetest. 8. Do not smoke, drink, or eat in areas where specimens or kit reagents arebeinghandled. 9. Dispose of all specimens and materials used to performthe test as biohazardouswaste. 10. Handle the negative and positive controls in the same manner as patientspecimens for operator protection. 11. Do not perform the test in a room with strong air flow, i.e. an electricfanorstrong air-conditioning. 12. Do not touch result window. 13. Use only for in-vitro diagnostic purpose.

“PA54 Specific Protein Analyzer performs tests in just three simple steps.it helps in monitoring of Inflamation, Rheumatism, Diabetes, Hemostasis, Renal Function, Cardivascular and immunological diseases.” Features: Parameters: HS-CRP, CRP, HbA1c, mALB, D-Dimer, Anti-CCP, RF, ASO, CYS-C, IgA, IgM, IgG, C3, C4, etc. Can be extended more than 30 parameters Sample type: Whole blood, serum, plasma, urine etc. Product Specification Model PA 54 Usage/Application Laboratory Use Display Type Digital Display 5.6 inches color touch screen Wavelength Range 650 nm Brand Operon Power supply AC 100-240V 50/60Hz Working temperature 10~30 degree C Memory 100,000 results storage Reaction time 1.5~3min Testing Channel 4 independent channels Light Source Diode laser Throughput 160 samples/hour

Cortisol Rapid Quantitative Test The Finecare™ Cortisol Rapid Quantitative Test is a fluorescence immunoassay for quantitative determination of Cortisol in human serum, plasma or whole blood. The test is used as an aid to the screening of adrenal dysfunction and assessment of the treatment effect. STORAGE AND STABILITY 1. Store the test kit at 4~30℃ up to the expiration date printed on package. 2. If removed from refrigerator, allow the test kit for 30 minutes to return to room temperature before testing. 3. Do not remove the test cartridge from the pouch until use. The test cartridge should be used within 1 hour once opened.

Total IgE Rapid Quantitative Test The Finecare™ Total IgE Rapid Quantitative Test along with Finecare™ FIA Meters is a fluorescence immunoassay for quantitative measurement of Total IgE in human whole blood, serum and plasma. The test is used as an aid in diagnosis of allergic disease.

ASO Rapid Quantitative Test The Finecare™ ASO Rapid Quantitative Test along with Finecare™ FIA Meters is a fluorescence immunoassay for quantitative measurement of Anti-streptolysin O (ASO) in human whole blood, serum and plasma. The test is used as an aid in the diagnosis of diseases related to streptococcal infections.